Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Beyond Air Inc (XAIR)

Beyond Air Inc (XAIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,099
  • Shares Outstanding, K 72,188
  • Annual Sales, $ 1,160 K
  • Annual Income, $ -60,240 K
  • EBIT $ -56 M
  • EBITDA $ -53 M
  • 60-Month Beta -0.23
  • Price/Sales 25.92
  • Price/Cash Flow N/A
  • Price/Book 0.67
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.41
  • Most Recent Earnings $-0.28 on 11/11/24
  • Next Earnings Date 02/10/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 590.52% ( +118.47%)
  • Historical Volatility 105.01%
  • IV Percentile 87%
  • IV Rank 39.04%
  • IV High 1,355.43% on 09/26/24
  • IV Low 100.69% on 04/08/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 29
  • Volume Avg (30-Day) 27
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 5,808
  • Open Int (30-Day) 5,671

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.18
  • Number of Estimates 2
  • High Estimate -0.13
  • Low Estimate -0.23
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +64.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4000 +0.78%
on 12/19/24
0.6761 -40.38%
on 11/26/24
-0.0885 (-18.00%)
since 11/20/24
3-Month
0.2960 +36.18%
on 10/01/24
0.6761 -40.38%
on 11/26/24
+0.0031 (+0.78%)
since 09/20/24
52-Week
0.2960 +36.18%
on 10/01/24
2.3599 -82.92%
on 12/27/23
-1.5069 (-78.90%)
since 12/20/23

Most Recent Stories

More News
Beyond Cancer, Ltd. Announces Phase 1b Clinical Trial Approval for LV UNO in Combination with PD-1 Therapy for Solid Tumor Patients

Phase 1b study of LV UNO in solid tumor patients approved in Israel, assessing efficacy and safety with anti-PD-1 therapy.Quiver AI SummaryBeyond Cancer, Ltd. has announced the approval from the Israeli...

XAIR : 0.4031 (-3.12%)
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

XAIR : 0.4031 (-3.12%)
Beyond Air, Inc. Receives CE Mark Approval for LungFit® PH System to Treat Newborns with Hypoxic Respiratory Failure and Pulmonary Hypertension, Triggering $1 Million Milestone Payment from Getz Healthcare

Beyond Air received CE mark approval for LungFit PH, enabling treatment for newborns and adults with pulmonary hypertension.Quiver AI SummaryBeyond Air, Inc. announced that it has received European CE...

XAIR : 0.4031 (-3.12%)
Beyond Air Receives CE Mark in Europe for the LungFit® PH System

XAIR : 0.4031 (-3.12%)
NeuroNOS Appoints Nobel Laureate Professor Roger D. Kornberg to Scientific Advisory Board to Advance Treatments for Autism Spectrum Disorder and Neurological Conditions

NeuroNOS appoints Nobel laureate Professor Roger D. Kornberg to its Scientific Advisory Board, enhancing its focus on neurological treatments.Quiver AI SummaryNeuroNOS, a biopharmaceutical company focused...

XAIR : 0.4031 (-3.12%)
NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

XAIR : 0.4031 (-3.12%)
Beyond Air, Inc. CEO Steve Lisi to Participate in Piper Sandler 36th Annual Healthcare Conference

Beyond Air's CEO to engage at the Piper Sandler Healthcare Conference on December 4, 2024, discussing the company's innovations.Quiver AI SummaryBeyond Air, Inc. announced that CEO Steve Lisi will engage...

XAIR : 0.4031 (-3.12%)
Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

XAIR : 0.4031 (-3.12%)
Beyond Air Stock Slides After Q2 Earnings Beat, Retail’s Confident

Retail sentiment on the stock turned ‘extremely bullish’ from ‘bullish’ a day ago.

IWC : 129.75 (+1.54%)
VXF : 192.94 (+1.36%)
XAIR : 0.4031 (-3.12%)
Beyond Air Stock Rises Ahead Of Earnings: Retail Bullish

Retail sentiment on the company inched up on Monday, rising to ‘bullish’ (67/100) from ‘neutral’ (46/100) a day ago.

IWC : 129.75 (+1.54%)
VXF : 192.94 (+1.36%)
XAIR : 0.4031 (-3.12%)

Business Summary

Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company. It is engaged in developing a Nitric Oxide Generator and Delivery System. The company's principal product is AirNOvent which is in clinical stage. Beyond Air Inc., formerly known as AIT Therapeutics Inc., is based in Garden...

See More

Key Turning Points

3rd Resistance Point 0.4616
2nd Resistance Point 0.4496
1st Resistance Point 0.4264
Last Price 0.4031
1st Support Level 0.3912
2nd Support Level 0.3792
3rd Support Level 0.3560

See More

52-Week High 2.3599
Fibonacci 61.8% 1.5715
Fibonacci 50% 1.3280
Fibonacci 38.2% 1.0844
Last Price 0.4031
52-Week Low 0.2960

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar